Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: ok who wrote (1120)	9/2/1998 8:29:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

Sepracor <SEPR.O> stages sharp rebound BOSTON, Sept 2 (Reuters) - Shares of drug company Sepracor Inc. surged on Wednesday, rebounding from sharp losses over the past week, analysts said. "They got beaten up pretty badly," said Rich Silver, an analyst with Lehman Brothers. "The stock's been definitely trading somewhat with the market. If you're asking me why the stock's up it's because it was oversold." Sepracor shares jumped 6-3/4 to 51-3/4 on Nasdaq. The stock hit a high of 60-12/16 last week before skidding late last week and early this week. Stock of the Marlborough, Mass.-based company has climbed since late July when it announced a collaboration with a unit of Johnson & Johnson <JNJ.N> to develop and market an improved version of the heartburn medication Propulsid. "That was a very big deal. That was an eye-opener," said David Steinberg, an analyst with Volpe Brown Whelan, who has a "strong buy" recommendation on the stock. "In the last two years, they've really had an impressive track record." 16:31 09-02-98 Copyright 1998 Reuters Limited. All rights reserved.